table of content
1 Introduction to Research & Analysis Reports
1.1 Lung Cancer Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Lung Cancer Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Lung Cancer Diagnostics Overall Market Size
2.1 Global Lung Cancer Diagnostics Market Size: 2022 VS 2030
2.2 Global Lung Cancer Diagnostics Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Lung Cancer Diagnostics Players in Global Market
3.2 Top Global Lung Cancer Diagnostics Companies Ranked by Revenue
3.3 Global Lung Cancer Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Lung Cancer Diagnostics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Lung Cancer Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Lung Cancer Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Lung Cancer Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Lung Cancer Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Lung Cancer Diagnostics Market Size Markets, 2022 & 2030
4.1.2 Immunoassays
4.1.3 Flow Cytometry
4.1.4 Rapid Tests
4.1.5 Molecular Assays
4.1.6 Tissue Arrays
4.1.7 Circulating Tumor Cells
4.1.8 Pharmacodiagnostics
4.1.9 Biomarkers
4.1.10 Other
4.2 By Type - Global Lung Cancer Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Lung Cancer Diagnostics Revenue, 2018-2023
4.2.2 By Type - Global Lung Cancer Diagnostics Revenue, 2024-2030
4.2.3 By Type - Global Lung Cancer Diagnostics Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Lung Cancer Diagnostics Market Size, 2022 & 2030
5.1.2 Industrial
5.1.3 Healthcare
5.1.4 Other
5.2 By Application - Global Lung Cancer Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Lung Cancer Diagnostics Revenue, 2018-2023
5.2.2 By Application - Global Lung Cancer Diagnostics Revenue, 2024-2030
5.2.3 By Application - Global Lung Cancer Diagnostics Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Lung Cancer Diagnostics Market Size, 2022 & 2030
6.2 By Region - Global Lung Cancer Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Lung Cancer Diagnostics Revenue, 2018-2023
6.2.2 By Region - Global Lung Cancer Diagnostics Revenue, 2024-2030
6.2.3 By Region - Global Lung Cancer Diagnostics Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Lung Cancer Diagnostics Revenue, 2018-2030
6.3.2 US Lung Cancer Diagnostics Market Size, 2018-2030
6.3.3 Canada Lung Cancer Diagnostics Market Size, 2018-2030
6.3.4 Mexico Lung Cancer Diagnostics Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Lung Cancer Diagnostics Revenue, 2018-2030
6.4.2 Germany Lung Cancer Diagnostics Market Size, 2018-2030
6.4.3 France Lung Cancer Diagnostics Market Size, 2018-2030
6.4.4 U.K. Lung Cancer Diagnostics Market Size, 2018-2030
6.4.5 Italy Lung Cancer Diagnostics Market Size, 2018-2030
6.4.6 Russia Lung Cancer Diagnostics Market Size, 2018-2030
6.4.7 Nordic Countries Lung Cancer Diagnostics Market Size, 2018-2030
6.4.8 Benelux Lung Cancer Diagnostics Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Lung Cancer Diagnostics Revenue, 2018-2030
6.5.2 China Lung Cancer Diagnostics Market Size, 2018-2030
6.5.3 Japan Lung Cancer Diagnostics Market Size, 2018-2030
6.5.4 South Korea Lung Cancer Diagnostics Market Size, 2018-2030
6.5.5 Southeast Asia Lung Cancer Diagnostics Market Size, 2018-2030
6.5.6 India Lung Cancer Diagnostics Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Lung Cancer Diagnostics Revenue, 2018-2030
6.6.2 Brazil Lung Cancer Diagnostics Market Size, 2018-2030
6.6.3 Argentina Lung Cancer Diagnostics Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Lung Cancer Diagnostics Revenue, 2018-2030
6.7.2 Turkey Lung Cancer Diagnostics Market Size, 2018-2030
6.7.3 Israel Lung Cancer Diagnostics Market Size, 2018-2030
6.7.4 Saudi Arabia Lung Cancer Diagnostics Market Size, 2018-2030
6.7.5 UAE Lung Cancer Diagnostics Market Size, 2018-2030
7 Lung Cancer Diagnostics Companies Profiles
7.1 Roche Diagnostics
7.1.1 Roche Diagnostics Company Summary
7.1.2 Roche Diagnostics Business Overview
7.1.3 Roche Diagnostics Lung Cancer Diagnostics Major Product Offerings
7.1.4 Roche Diagnostics Lung Cancer Diagnostics Revenue in Global Market (2018-2023)
7.1.5 Roche Diagnostics Key News & Latest Developments
7.2 BioM?rieux
7.2.1 BioM?rieux Company Summary
7.2.2 BioM?rieux Business Overview
7.2.3 BioM?rieux Lung Cancer Diagnostics Major Product Offerings
7.2.4 BioM?rieux Lung Cancer Diagnostics Revenue in Global Market (2018-2023)
7.2.5 BioM?rieux Key News & Latest Developments
7.3 Qiagen
7.3.1 Qiagen Company Summary
7.3.2 Qiagen Business Overview
7.3.3 Qiagen Lung Cancer Diagnostics Major Product Offerings
7.3.4 Qiagen Lung Cancer Diagnostics Revenue in Global Market (2018-2023)
7.3.5 Qiagen Key News & Latest Developments
7.4 Advpharma
7.4.1 Advpharma Company Summary
7.4.2 Advpharma Business Overview
7.4.3 Advpharma Lung Cancer Diagnostics Major Product Offerings
7.4.4 Advpharma Lung Cancer Diagnostics Revenue in Global Market (2018-2023)
7.4.5 Advpharma Key News & Latest Developments
7.5 AIT Austrian Institute of Technology
7.5.1 AIT Austrian Institute of Technology Company Summary
7.5.2 AIT Austrian Institute of Technology Business Overview
7.5.3 AIT Austrian Institute of Technology Lung Cancer Diagnostics Major Product Offerings
7.5.4 AIT Austrian Institute of Technology Lung Cancer Diagnostics Revenue in Global Market (2018-2023)
7.5.5 AIT Austrian Institute of Technology Key News & Latest Developments
7.6 Courtagen Life Sciences
7.6.1 Courtagen Life Sciences Company Summary
7.6.2 Courtagen Life Sciences Business Overview
7.6.3 Courtagen Life Sciences Lung Cancer Diagnostics Major Product Offerings
7.6.4 Courtagen Life Sciences Lung Cancer Diagnostics Revenue in Global Market (2018-2023)
7.6.5 Courtagen Life Sciences Key News & Latest Developments
7.7 DiagnoCure
7.7.1 DiagnoCure Company Summary
7.7.2 DiagnoCure Business Overview
7.7.3 DiagnoCure Lung Cancer Diagnostics Major Product Offerings
7.7.4 DiagnoCure Lung Cancer Diagnostics Revenue in Global Market (2018-2023)
7.7.5 DiagnoCure Key News & Latest Developments
7.8 BioMark Diagnostics
7.8.1 BioMark Diagnostics Company Summary
7.8.2 BioMark Diagnostics Business Overview
7.8.3 BioMark Diagnostics Lung Cancer Diagnostics Major Product Offerings
7.8.4 BioMark Diagnostics Lung Cancer Diagnostics Revenue in Global Market (2018-2023)
7.8.5 BioMark Diagnostics Key News & Latest Developments
7.9 Mayo Clinic
7.9.1 Mayo Clinic Company Summary
7.9.2 Mayo Clinic Business Overview
7.9.3 Mayo Clinic Lung Cancer Diagnostics Major Product Offerings
7.9.4 Mayo Clinic Lung Cancer Diagnostics Revenue in Global Market (2018-2023)
7.9.5 Mayo Clinic Key News & Latest Developments
7.10 HalioDx SAS
7.10.1 HalioDx SAS Company Summary
7.10.2 HalioDx SAS Business Overview
7.10.3 HalioDx SAS Lung Cancer Diagnostics Major Product Offerings
7.10.4 HalioDx SAS Lung Cancer Diagnostics Revenue in Global Market (2018-2023)
7.10.5 HalioDx SAS Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
